TRial to Evaluate UltraSound in the Treatment of Tibial Fractures

Conditions:		Tibial Fractures
Purpose:		The purpose of this study is to determine the effect of low-intensity, pulsed ultrasound on tibial fractures treated with intramedullary nailing.
Study Summary:		A randomized, placebo-treatment controlled, clinical trial to evaluate the safety and efficacy of low-intensity, pulsed ultrasound, applied to tibial fractures treated with intramedullary nailing.
Criteria:		Inclusion Criteria: - Males and females age 18 years or older - Have an open or closed tibial fracture amenable to intramedullary nail fixation Exclusion Criteria: - Tibial fracture associated with a vascular injury requiring repair - Pilon fractures - Tibial fractures that extend into the joint and require reduction - Pathologic fractures • Bilateral tibial fractures
NCT ID:		NCT00667849
Primary Contact:		Principal Investigator Mohit Bhandari, MD McMaster University Brett Gordon, BS Phone: 919-474-6747 Email: brett.gordon@smith-nephew.com
Backup Contact:		Email: edward.philpot@smith-nephew.com Edward Philpot, M.D. Phone: 919-474-6777
Location Contact:		Morgantown, West Virginia 26506 United States *There is no listed contact information for this specific location.* Site Status: Recruiting

Data Source:		ClinicalTrials.gov
Date Processed:		May 21, 2013
Modifications to this listing:		Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"

First Name:

Last Name:

Email Address:

Confirm Email:

Daytime Phone (eg. 555-555-5555):

City:

State:

Zip Code:

Best Time to Call:

Morning	Afternoon	Evening
Please contact me by email instead of calling.

Questions/Comments:

I have read and agree with the Privacy Policy

I have reviewed the eligibility criteria and believe I am eligible for this clinical trial

I would like to be notified about new clinical trials.